• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉粥样硬化形成过程中树突状细胞与T淋巴细胞之间的相互作用:聚焦于抗原呈递与免疫耐受的打破。

Crosstalk between dendritic cells and T lymphocytes during atherogenesis: Focus on antigen presentation and break of tolerance.

作者信息

Bellini Rossella, Bonacina Fabrizia, Norata Giuseppe Danilo

机构信息

Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.

Center for the Study of Atherosclerosis, E. Bassini Hospital, Cinisello Balsamo, Milan, Italy.

出版信息

Front Cardiovasc Med. 2022 Jul 28;9:934314. doi: 10.3389/fcvm.2022.934314. eCollection 2022.

DOI:10.3389/fcvm.2022.934314
PMID:35966516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9365967/
Abstract

Atherosclerosis is a chronic disease resulting from an impaired lipid and immune homeostasis, where the interaction between innate and adaptive immune cells leads to the promotion of atherosclerosis-associated immune-inflammatory response. Emerging evidence has suggested that this response presents similarities to the reactivity of effector immune cells toward self-epitopes, often as a consequence of a . In this context, dendritic cells, a heterogeneous population of antigen presenting cells, play a key role in instructing effector T cells to react against foreign antigens and T regulatory cells to maintain tolerance against self-antigens and/or to patrol for self-reactive effector T cells. Alterations in this delicate balance appears to contribute to atherogenesis. The aim of this review is to discuss different DC subsets, and their role in atherosclerosis as well as in T cell polarization. Moreover, we will discuss how loss of T cell tolerogenic phenotype participates to the immune-inflammatory response associated to atherosclerosis and how a better understanding of these mechanisms might result in designing immunomodulatory therapies targeting DC-T cell crosstalk for the treatment of atherosclerosis-related inflammation.

摘要

动脉粥样硬化是一种因脂质和免疫稳态受损而引发的慢性疾病,在这种疾病中,固有免疫细胞和适应性免疫细胞之间的相互作用会促进与动脉粥样硬化相关的免疫炎症反应。新出现的证据表明,这种反应与效应免疫细胞对自身表位的反应性存在相似之处,这通常是由于……的结果。在这种情况下,树突状细胞作为一种异质性的抗原呈递细胞群体,在指导效应T细胞对外来抗原作出反应以及调节性T细胞维持对自身抗原的耐受性和/或巡查自身反应性效应T细胞方面发挥着关键作用。这种微妙平衡的改变似乎会促进动脉粥样硬化的发生。本综述的目的是讨论不同的树突状细胞亚群及其在动脉粥样硬化以及T细胞极化中的作用。此外,我们将讨论T细胞耐受性表型的丧失如何参与与动脉粥样硬化相关的免疫炎症反应,以及对这些机制的更好理解如何可能导致设计针对树突状细胞 - T细胞相互作用的免疫调节疗法来治疗动脉粥样硬化相关炎症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5b/9365967/4dd5d11ae006/fcvm-09-934314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5b/9365967/4dd5d11ae006/fcvm-09-934314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e5b/9365967/4dd5d11ae006/fcvm-09-934314-g001.jpg

相似文献

1
Crosstalk between dendritic cells and T lymphocytes during atherogenesis: Focus on antigen presentation and break of tolerance.动脉粥样硬化形成过程中树突状细胞与T淋巴细胞之间的相互作用:聚焦于抗原呈递与免疫耐受的打破。
Front Cardiovasc Med. 2022 Jul 28;9:934314. doi: 10.3389/fcvm.2022.934314. eCollection 2022.
2
The benefits of diversity: heterogenous DC populations allow for both immunity and tolerance.多样性的益处:异质性树突状细胞群体可实现免疫与耐受。
J Theor Biol. 2014 Sep 21;357:86-102. doi: 10.1016/j.jtbi.2014.04.034. Epub 2014 May 9.
3
Dendritic cells in atherogenesis: possible novel targets for prevention of atherosclerosis.动脉粥样硬化形成中的树突状细胞:预防动脉粥样硬化的可能新靶点。
J Atheroscler Thromb. 2012;19(11):953-61. doi: 10.5551/jat.14134. Epub 2012 Aug 9.
4
Functional crosstalk between dendritic cells and Foxp3(+) regulatory T cells in the maintenance of immune tolerance.树突状细胞与 Foxp3(+)调节性 T 细胞之间的功能串扰在免疫耐受维持中的作用。
Front Immunol. 2012 Jun 22;3:165. doi: 10.3389/fimmu.2012.00165. eCollection 2012.
5
Myeloid dendritic cells: Development, functions, and role in atherosclerotic inflammation.髓样树突状细胞:发育、功能及在动脉粥样硬化炎症中的作用
Immunobiology. 2015 Jun;220(6):833-44. doi: 10.1016/j.imbio.2014.12.010. Epub 2015 Jan 5.
6
Current advances in understanding of immunopathology of atherosclerosis.当前对动脉粥样硬化免疫病理学认识的进展。
Virchows Arch. 2011 Feb;458(2):117-23. doi: 10.1007/s00428-010-1006-5. Epub 2010 Nov 11.
7
Autoimmune Regulator (AIRE) Deficiency Does Not Affect Atherosclerosis and CD4 T Cell Immune Tolerance to Apolipoprotein B.自身免疫调节因子(AIRE)缺乏不影响动脉粥样硬化及CD4 T细胞对载脂蛋白B的免疫耐受。
Front Cardiovasc Med. 2022 Jan 13;8:812769. doi: 10.3389/fcvm.2021.812769. eCollection 2021.
8
Impaired Autophagy in CD11b Dendritic Cells Expands CD4 Regulatory T Cells and Limits Atherosclerosis in Mice.树突状细胞自噬功能受损可扩增 CD4 调节性 T 细胞并限制小鼠动脉粥样硬化
Circ Res. 2019 Nov 8;125(11):1019-1034. doi: 10.1161/CIRCRESAHA.119.315248. Epub 2019 Oct 15.
9
Targeting dendritic cells for priming cellular immune responses.靶向树突状细胞以启动细胞免疫反应。
J Mol Recognit. 2003 Sep-Oct;16(5):299-317. doi: 10.1002/jmr.650.
10
Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease.用于预防动脉粥样硬化性心血管疾病的抗炎和免疫调节疗法。
J Cardiol. 2015 Jul;66(1):1-8. doi: 10.1016/j.jjcc.2015.02.002. Epub 2015 Mar 2.

引用本文的文献

1
Oxidized Low-Density Lipoprotein and Its Role in Immunometabolism.氧化型低密度脂蛋白及其在免疫代谢中的作用。
Int J Mol Sci. 2024 Oct 23;25(21):11386. doi: 10.3390/ijms252111386.
2
Hypercholesterolemia and inflammation-Cooperative cardiovascular risk factors.高胆固醇血症与炎症——协同作用的心血管危险因素。
Eur J Clin Invest. 2025 Jan;55(1):e14326. doi: 10.1111/eci.14326. Epub 2024 Oct 6.
3
Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling.

本文引用的文献

1
Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors.单克隆抗体在家族性高胆固醇血症治疗中的应用:聚焦于前蛋白转化酶枯草溶菌素 9(PCSK9)和血管生成素样蛋白 3(ANGPTL3)抑制剂。
Curr Atheroscler Rep. 2021 Oct 26;23(12):79. doi: 10.1007/s11883-021-00972-x.
2
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target.载脂蛋白B与心血管疾病:生物标志物及潜在治疗靶点
Metabolites. 2021 Oct 8;11(10):690. doi: 10.3390/metabo11100690.
3
Macrophages and Foam Cells: Brief Overview of Their Role, Linkage, and Targeting Potential in Atherosclerosis.
甲巯咪唑可通过增加免疫抑制细胞和降低与促炎、钙化和组织重塑相关基因的表达来治疗动脉粥样硬化。
J Immunol Res. 2024 Jul 23;2024:5009637. doi: 10.1155/2024/5009637. eCollection 2024.
4
Autoimmune diseases and atherosclerotic cardiovascular disease.自身免疫性疾病与动脉粥样硬化性心血管疾病。
Nat Rev Cardiol. 2024 Nov;21(11):780-807. doi: 10.1038/s41569-024-01045-7. Epub 2024 Jun 27.
5
Cells in Atherosclerosis: Focus on Cellular Senescence from Basic Science to Clinical Practice.动脉粥样硬化中的细胞:从基础科学到临床实践聚焦于细胞衰老。
Int J Mol Sci. 2023 Dec 5;24(24):17129. doi: 10.3390/ijms242417129.
6
Revisiting regulatory T cells as modulators of innate immune response and inflammatory diseases.重新审视调节性 T 细胞作为先天免疫反应和炎症性疾病的调节剂。
Front Immunol. 2023 Oct 20;14:1287465. doi: 10.3389/fimmu.2023.1287465. eCollection 2023.
7
Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis.靶向肠道微生物群与免疫串扰:天然产物治疗动脉粥样硬化的潜在机制
Front Pharmacol. 2023 Sep 1;14:1252907. doi: 10.3389/fphar.2023.1252907. eCollection 2023.
8
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes.动脉粥样硬化与炎症:通论病理过程学说的启示。
Int J Mol Sci. 2023 Apr 26;24(9):7910. doi: 10.3390/ijms24097910.
9
Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progression.树突状细胞标志物Clec4a4缺陷限制动脉粥样硬化进展。
Atheroscler Plus. 2022 Dec 17;51:8-12. doi: 10.1016/j.athplu.2022.12.001. eCollection 2023 Mar.
10
Autoantibodies to Oxidatively Modified Peptide: Potential Clinical Application in Coronary Artery Disease.氧化修饰肽自身抗体:在冠状动脉疾病中的潜在临床应用
Diagnostics (Basel). 2022 Sep 20;12(10):2269. doi: 10.3390/diagnostics12102269.
巨噬细胞与泡沫细胞:动脉粥样硬化中它们的作用、联系及靶向潜力概述
Biomedicines. 2021 Sep 14;9(9):1221. doi: 10.3390/biomedicines9091221.
4
Promoting athero-protective immunity by vaccination with low density lipoprotein-derived antigens.通过接种低密度脂蛋白衍生抗原促进动脉保护免疫。
Atherosclerosis. 2021 Oct;335:89-97. doi: 10.1016/j.atherosclerosis.2021.08.033. Epub 2021 Aug 25.
5
Immune cell profiling in atherosclerosis: role in research and precision medicine.动脉粥样硬化中的免疫细胞分析:在研究和精准医学中的作用。
Nat Rev Cardiol. 2022 Jan;19(1):43-58. doi: 10.1038/s41569-021-00589-2. Epub 2021 Jul 15.
6
Regulatory T Cell-Enhancing Therapies to Treat Atherosclerosis.调节性 T 细胞增强疗法治疗动脉粥样硬化。
Cells. 2021 Mar 24;10(4):723. doi: 10.3390/cells10040723.
7
ApoB-Specific CD4 T Cells in Mouse and Human Atherosclerosis.载脂蛋白 B 特异性 CD4 T 细胞在鼠和人动脉粥样硬化中的作用。
Cells. 2021 Feb 19;10(2):446. doi: 10.3390/cells10020446.
8
CD8 T Cells in Atherosclerosis.动脉粥样硬化中的 CD8 T 细胞。
Cells. 2020 Dec 29;10(1):37. doi: 10.3390/cells10010037.
9
Scavenger receptor MARCO contributes to cellular internalization of exosomes by dynamin-dependent endocytosis and macropinocytosis.清道夫受体 MARCO 通过网格蛋白依赖的内吞作用和胞饮作用促进外泌体的细胞内化。
Sci Rep. 2020 Dec 11;10(1):21795. doi: 10.1038/s41598-020-78464-2.
10
Adoptive transfer of CX3CR1 transduced-T regulatory cells improves homing to the atherosclerotic plaques and dampens atherosclerosis progression.过继转移CX3CR1转导的调节性T细胞可改善归巢至动脉粥样硬化斑块的情况,并抑制动脉粥样硬化进展。
Cardiovasc Res. 2021 Jul 27;117(9):2069-2082. doi: 10.1093/cvr/cvaa264.